Newsroom
340B In The News
September 24, 2018
GAO Raises Additional Concerns With 340B Contract Pharmacies and Hospitals
The 340B drug discount program — a vital safety-net program created to help millions of vulnerable or uninsured patients receive care — is no longer benefiting many of the patients it was meant to serve. That’s according to mounting findings from congressional investigations, independent economists, and government watchdogs. Two new studies released by the Government Accountability Office (GAO) add to these growing concerns, looking specifically at contract pharmacies and hospitals in the 340B program. GAO’s latest conclusions provide further evidence more must be done to fix the 340B program and bring it back to the original intent of helping patients.
340B In The News
September 18, 2018
AIR340B Encouraged by 340B Principles Announced by AHA, Looks to Regulatory and Congressional Action to Keep Momentum Going
The AIR340B Coalition issued the following statement in response to the new principles for good stewardship of the 340B program announced by the American Hospital Association (AHA) today.
340B In The News
August 29, 2018
“A Little-Known Windfall for Some Hospitals, Now Facing Big Cuts”
A program meant to help the poor has grown beyond its original intent.
340B In The News
July 23, 2018
“PAUSE Act a responsible approach toward reforming the 340B drug pricing program”
With 340B being back in the news and with beneficial legislation in the works, I wanted to take the opportunity to reshare my thoughts.
340B In The News
July 19, 2018
“Save The Safety Net Drug Program For Patients Who Need Help”
A poster on the side of a bus stop in downtown Washington D.C. read: “Let 340B,” clearly a sign of an organized campaign asking Congress not to interfere with the gravy train for some hospital systems that this obscure provision has become.
340B In The News
July 12, 2018
“Our Exclusive Analysis: Nearly One in Three U.S. Pharmacies Is a 340B Contract Pharmacy; Five Chains Dominate”
Pharmacies continue to profit from the 340B Drug Pricing Program’s explosive growth.
340B In The News
June 12, 2018
“Commentary: Drug discount program aiding profits not patients”
Reforms are needed to a 1992 law intended to keep medication costs low for low-income patients.